EXC vs STRO
Exelon Corporation (EXC) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the EXC and STRO stock pages for the full models.
Not investment advice.